Sarcoidosis mimicking breast cancer: a staging challenge

ABSTRACT

Sarcoidosis is often an asymptomatic condition. Most patient are unaware of their diagnostic. It has specific pathological characteristics at microscopic evaluation; however, in imaging tests it can mimic other conditions. Breast cancer is the most common cancer among women. Staging breast cancer patients with sarcoidosis can be challenging as the differential diagnosis between sarcoidosis lesions and metastasis can be difficult by radiologic evaluations. Here we describe the conduction of such a case highlighting the importance of the clinical evaluation and the utility of complementary imaging tests and tissue evaluation in this setting.

RESUMO

A sarcoidose é uma condição frequentemente assintomática. A maioria dos pacientes desconhecem seu diagnóstico. Possui características patológicas específicas na avaliação microscópica, mas em testes de imagem pode imitar outras condições. O câncer de mama é o câncer mais comum entre as mulheres. O estadiamento de pacientes com câncer de mama com sarcoidose pode ser desafiador, pois o diagnóstico diferencial entre lesões de sarcoidose e metástase pode ser difícil por avaliações radiológicas. Aqui, descrevemos a condução de um caso desse tipo, destacando a importância da avaliação clínica e a utilidade dos exames complementares de imagem e avaliação tecidual nesse cenário.

Keywords:

Breast neoplasms - Sarcoidosis - Positron-emission tomography - Neoplasm metastasis

Descritores:

Neoplasias da mama - Sarcoidose - Tomografia por emissão de pósitrons - Metástase de neoplasia

INTRODUCTION

Sarcoidosis is a multisystem inflammatory disorder of unknown etiology and, in general, self-limited.([1]) Typically, it affects young adults with an incidence of 1.0-35.5/100.000 per year, developing more commonly in the lymphatic system and lungs, although other organs may be involved.([2]) Clinical manifestations are variable and non-specific, such as cough, dyspnea, lymphadenopathy, skin rashes, arthralgia, uveitis and hepatosplenomegaly. Half of the patients have their condition detected by incidental radiographic alterations, being asymptomatic in the moment of the diagnosis.([2] [3])

There is controversy between the relation of sarcoidosis and cancer. The main hypothesis is that the immunological dysfunction and the chronic inflammation may contribute to the development of malignancies. According to the meta-analysis presented by Bonifazi et al. (2015)([4]) and Ungprasert et al. (2015),([5]) data is conflicting and not robust enough to establish a concrete association between these conditions.

It has been previously described the development of sarcoidosis after a cancer diagnosis, mimicking metastatic implants.([6]) Nonetheless, the co-presence of sarcoidosis and breast cancer is uncommon and consists in an important differential diagnosis to be considered.([7]) Here, we describe a case of breast cancer initially thought to be metastatic with large lymph node commitment and pulmonary lymphangitis, by imaging tests. This was in contrast with and excellent clinical condition, which triggered a more detailed evaluation of the supposed metastatic lesions.

CASE REPORT

KCT, Caucasian, 48-years-old woman in a screening mammogram it was detected a 3,3cm nodule in the left breast classified as BIRADS-4C. The core biopsy of the breast lesion revealed a grade 2 invasive ductal carcinoma, ER 100%, PR 5%, HER2-negative, ki67 25%. She had clinically and radiologically negative axillary lymph nodes.

She had a positive familiar history of cancer, her mother had breast cancer at the age of 62-yearsold, maternal grandmother with thyroid cancer at 58-years-old and paternal aunt had gynecological cancer at 62-years-old.

She was treated with left breast lumpectomy and sentinel lymph node dissection. The anatomopathological examination confirmed the histological subtype, size and the negative sentinel lymph node. She was then referred to the oncology department for adjuvant treatment evaluation.

Her computerized tomography (CT scan) was ordered, evidencing interstitial pulmonary lesions, thickening in the peribronchial region and micronodules in the right lung and liver. These findings were described as suspected for metastatic lesions and lymphangitic carcinomatosis. At that moment she was asymptomatic, the clinical condition was not concordant with the suggested diagnosis by the CT images ([Figure 1]). A PET/CT was then ordered. The exam shown intense FDG uptake in the spleen in inguinal and iliac lymph nodes and moderate uptake in some hepatic lesions. There was no FDG uptake in the lungs ([Figure 2]).

Figure 1 Chest CT showing images described as lymphangitic carcinomatosis.

Figure 2 PET/CT evidencing intense FDG uptake in the spleen, iliac and inguinal lymph nodes and absence of contrast uptake in the lungs.

Considering the areas shown in the PET/CT, it was necessary to evaluate the histology of the metabolic active lesions. We proceeded with a liver biopsy in which the histological examination revealed a histiocytic infiltrate with formation of an epithelioid granuloma without necrosis, confirming the diagnosis of sarcoidosis ([Figure 3]).

Figure 3 Liver biopsy evidencing a sarcoidosis granuloma.

With these results, the final stage of the patient was pT2pN0. Patient was treated with adjuvant chemotherapy with docetaxel and cyclophosphamide for four cycles, followed by radiotherapy. She is currently disease free in hormone therapy (Tamoxifen 20mg/day) without major side effects.

DISCUSSION

Sarcoidosis and breast cancer are distinct diseases that affect females, mainly in middle age.([8]) The association between these two diseases is a rare phenomenon and have been reported in the medical literature mostly in clinical cases.([8] [9] [10] [11] [12] [13] [14])

The correlation between sarcoidosis and carcinogenesis remains unclear and several chronological associations are described. High frequency of sarcoidosis after lymphoma and breast cancer was observed.([6]) Meta-analysis pointed increase risk of skin, hematopoietic, upper digestive tract, kidney, liver and colorectal cancers, in patients with sarcoidosis.([5]) Breast cancer may precede the development of sarcoidosis or the opposite.([6] [7]) Still, both can be diagnosed simultaneously, leading to important challenges in diagnosis and cancer staging.([6] [7] [8])

The difference between sarcoidosis and malignancy can be challenge. Although breast involvement is uncommon, palpable masses show the same characteristics that breast tumors. The possibility of axillary lymphadenopathy is also common to both conditions. Conventional imaging exams such as mammography and ultrasound have little value in disease differential.([7] [8])

Metastatic lesions are the most important differential diagnosis to be excluded.([8]) PET/CT is useful in the detection of distant metastases in patients with breast cancer, in particular when conventional imaging techniques are not conclusive. However, its results should be interpreted considering the clinical condition to avoid false positive results.([8]) PET/CT has high sensitivity and may be positive in a myriad of conditions such as the great majority of solid tumors, hematologic malignancies([9]) and other nonmalignant conditions as tuberculosis, fungal infections and sarcoidosis.([8]) Furthermore, in patients with granulomatous process, the standardized uptake value (SUV) may be similar to that of cancer patients and may generate diagnostic doubts,([10]) as in this study.

In this case, the atypical and diffuse distribution FDG uptake was not compatible with the common pattern for breast cancer to metastasize and dissociated of the clinical condition. We would expect a patient with multiple metastasis to be symptomatic of the disease. Histological evaluation of a tissue biopsy remains as the gold standard for differentiating metastasis from other diseases.([10])

This case highlights the importance of the clinical evaluation and the complementary nature of imaging tests. Complementary tests should be interpreted in the light of the clinical findings to prevent misdiagnosis and over treatment.

Conflicts of interest

The authors declare no conflict of interest relevant to this manuscript.

AUTHOR'S CONTRIBUTION

Antonio Augusto Claudio Pereira: Collection and assembly of data, Conception and design, Data analysis and interpretation, Final approval of manuscript, Manuscript writing, Provision of study materials or patient.

Rebecca Dias Zaia: Collection and assembly of data, Conception and design, Data analysis and interpretation, Final approval of manuscript, Manuscript writing, Provision of study materials or patient.

Denise Oishi: Final approval of manuscript, Provision of study materials or patient

Maria Regina Vianna: Data analysis and interpretation, Final approval of manuscript, Provision of study materials or patient.

Flávio Pimentel: Final approval of manuscript, Provision of study materials or patient

Felipe Ades: Collection and assembly of data, Conception and design, Data analysis and interpretation, Final approval of manuscript, Manuscript writing, Provision of study materials or patient

• REFERENCES

• Bokhari SRA, Zulfiqar H, Mansur A. Sarcoidosis [Internet]. Treasure Island (FL): StatPearls Publishing; 2018. Jan access in ANO Mês dia Available from: https://www.ncbi.nlm.nih.gov/books/NBK430687
• Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Müller-Quernheim J. Sarcoidose. Lancet 2014; Mar; 383 (9923) 1155-1167 https://doi.org/10.1016/s0140-6736(13)60680-7
• Ungprasert P, Crowson CS, Matteson EL. Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota. Reumatismo 2017; 69 (01) 16-22 https://doi.org/10.4081/reumatismo.2017.965
• Bonifazi M, Bravi F, Gasparini S, La Vecchia C, Gabrielli A, Wells AU. et al Sarcoidosis and cancer risk. Chest 2015; Mar; 147 (03) 778-791 https://doi.org/10.1378/chest.14-1475
• Ungprasert P, Srivali N, Wijarnpreecha K, Thongprayoon C, Cheungpasitporn W, Knight EL. Is the incidence of malignancy increased in patients with sarcoidosis? A systematic review and meta-analysis. Respirology 2014; 19 (07) 993-998 https://doi.org/10.1111/resp.12369
• Arish N, Kuint R, Sapir E, Levy L, Abutbul A, Fridlender Z. et al Characteristics of sarcoidosis in patients with previous malignancy: causality or coincidence?. Respiration 2017; 93: 247-252 https://doi.org/10.1159/000455877
• Chen J, Carter R, Maoz D, Tobar A, Sharon E, Greif F. Breast cancer and sarcoidosis: case series and review of the literature. Breast Care (Basel) 2014; Apr; 10 (02) 137-140
• Altinkaya M, Altinkaya N, Hazar B. Sarcoidosis mimicking metastatic breast cancer in a patient with early-stage breast cancer. Ulusal Cerrahi Dergisi 2015; Jul; 32 (01) 71-74 https://doi.org/10.5152/UCD.2015.2989
• Oskuei A, Hicks L, Ghaffar H, Hoffstein V. Sarcoidosis-lymphoma syndrome: a diagnostic dilemma. BMJ Case Rep 2017; Dec; bcr-2017-220065 https://doi.org/10.1136/bcr-2017-220065
• Kochoyan T, Akhmedov M, Shabanov A, Terekhov I. Sarcoidosis imitating breast cancer metastasis: a case report and literature review. Cancer Biol Med 2016; Sep; 13 (03) 396-398
• Zivin S, Odile D, Yang L. Sarcoidosis mimicking metastatic breast cancer on FDG PET/CT. Intern Med (Tokyo, Japan) 2014; 53 (21) 2555-2556 https://doi.org/10.2169/internalmedicine.53.3333
• Hye KK, Suk-Young L, Oh SC, Chul WC, Jun SK, Jae HS. Case report of pulmonary sarcoidosis suspected to be pulmonary metastasis in a patient with breast cancer. Cancer Res Treat 2014; 46 (03) 317-321 https://doi.org/10.4143/crt.2014.46.3.317
• Akhtari M, Quesada JR, Schwartz MR, Chiang SB, Teh BS. Sarcoidosis presenting as metastatic lymphadenopathy in breast cancer (2014). Clin Breast Cancer 2014; Oct; 14 (05) e107-e110
• Paone G, Di Lascio S, Azzola A, Mazzucchelli L, Pagani O. Unusual case of splenic sarcoidosis without morphological lesions detected by PETCT in a patient with breast cancer: functional imaging between pitfalls and therapeutic guide. ECancer 2017; 11: 766 https://doi.org/10.3332/ecancer.2017.766

Publication History

Received: 25 September 2019

Accepted: 11 May 2020

Article published online:
02 July 2020